Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Assets Average (2016 - 2025)

vTv Therapeutics' Assets Average history spans 11 years, with the latest figure at $63.0 million for Q3 2025.

  • For Q3 2025, Assets Average rose 40.53% year-over-year to $63.0 million; the TTM value through Sep 2025 reached $63.0 million, up 40.53%, while the annual FY2024 figure was $24.6 million, 11.36% up from the prior year.
  • Assets Average for Q3 2025 was $63.0 million at vTv Therapeutics, up from $29.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $63.0 million in Q3 2025 and bottomed at $13.0 million in Q4 2023.
  • The 5-year median for Assets Average is $29.2 million (2025), against an average of $31.4 million.
  • The largest annual shift saw Assets Average tumbled 62.27% in 2023 before it surged 213.89% in 2024.
  • A 5-year view of Assets Average shows it stood at $28.5 million in 2021, then increased by 20.82% to $34.4 million in 2022, then crashed by 62.27% to $13.0 million in 2023, then soared by 213.89% to $40.7 million in 2024, then soared by 54.66% to $63.0 million in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Assets Average are $63.0 million (Q3 2025), $29.2 million (Q2 2025), and $35.1 million (Q1 2025).